1-5 of 5
Andreas Sarris
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Impact of Therapeutic Management and Prognostic Factors on the Outcome of Primary Cutaneous B-Cell Lymphomas (PCBCL) (IELSG 11 Study)

Sergio Cortelazzo, MD, Michael Mian, MD, Maria Cantonetti, MD, Andreas Sarris, MD, Andrea Rossi, MD, Alessandro Rambaldi, MD, Giuseppe Lombardo, MD, Felice Pasini, MD, Achille Ambrosetti, MD, Liliana Devizzi, MD, Mario Busetto, MD, Osnat Bairey, MD, Emilio Berti, MD, Giovanni Martinelli, MD, Richard Tsang, MD, Silvia Rudoy, MD, Robert Blum, MD, Andres JM Ferreri, MD, Graziella Pinotti, MD, Enrico Pogliani, MD, Emanuele Zucca, MD
Journal: Blood
Blood (2008) 112 (11): 3608.
https://doi.org/10.1182/blood.V112.11.3608.3608
Published: 2008
Journal Articles

Results of a Phase II Study of 506U78 (Nelarabine) in Refractory Indolent B-Cell or Peripheral T-Cell Lymphoma.

Michael A. Thompson, MD, PhD, Barbara Pro, MD, Andreas Sarris, MD, PhD, Fredrick B. Hagemeister, MD, Andre Goy, MD, Archie Bleyer, MD, Fernando F. Cabanillas, MD, Felipe Samaniego, MD, MPH, Luis E. Fayad, MD
Journal: Blood
Blood (2005) 106 (11): 2681.
https://doi.org/10.1182/blood.V106.11.2681.2681
Published: 2005
Journal Articles

Sphingosomal Vincristine in CHOP +/− Rituximab Is a Promising New Treatment for Patients with High Risk Untreated Aggressive Non-Hodgkin’s Lymphoma (NHL): Follow-Up Results of a Phase II Study Sphingosomal Vincristine in CHOP +/− Rituximab Is a Promising New Treatment for Patients with High Risk Untreated Aggressive Non-Hodgkin’s Lymphoma (NHL): Follow-Up Results of a Phase II Study.

Maria Alma Rodriguez, M.D., Andreas Sarris, M.D., Nam H. Dang, M.D., Luis Fayad, M.D., Andre Goy, M.D., Fredrick Hagemeister, M.D., Peter McLaughlin, M.D., Barbara Pro, M.D., Jorge Romaguera, M.D., Felipe Samaniego, M.D., Anas Younes, M.D., Fernando Cabanillas, M.D.
Journal: Blood
Blood (2004) 104 (11): 4602.
https://doi.org/10.1182/blood.V104.11.4602.4602
Published: 2004
Journal Articles

Fludarabine, mitoxantrone, dexamethasone (FND) compared with an alternating triple therapy (ATT) regimen in patients with stage IV indolent lymphoma

Clinical Trials & Observations
Apostolia M. Tsimberidou, Peter McLaughlin, Anas Younes, Maria A. Rodriguez, Fredrick B. Hagemeister, Andreas Sarris, Jorge Romaguera, Mark Hess, Terry L. Smith, Ying Yang, Ana Ayala, Alejandro Preti, Ming-Sheng Lee, Fernando Cabanillas
Journal: Blood
Blood (2002) 100 (13): 4351–4357.
https://doi.org/10.1182/blood-2001-12-0269
Published: 2002
Journal Articles

Risk Factors, Treatment, and Outcome of Central Nervous System Recurrence in Adults With Intermediate-Grade and Immunoblastic Lymphoma

Koen van Besien, Chul S. Ha, Sandy Murphy, Peter McLaughlin, Alma Rodriguez, Kamal Amin, Arthur Forman, Jorge Romaguera, Fredrick Hagemeister, Anas Younes, Carlos Bachier, Andreas Sarris, Kathleen S. Sobocinski, James D. Cox, Fernando Cabanillas
Journal: Blood
Blood (1998) 91 (4): 1178–1184.
https://doi.org/10.1182/blood.V91.4.1178
Published: 1998